Pharmacology CCR
Pharmacology CCR
General criticism:
1. Doctor’s and patient’s information are not given.
2. Symbol Rx is not given.
3. Abbreviations are used.
4. Duration and time of administration are not given.
5. Roman numeral IV is used
Drug criticism:
Glibenclamide and Metformin are oral hypoglycaemic agents and are used in type 2 diabetic
patients. The drug of choice is regular insulin in this case.
Dose criticism:
The dose of insulin is not mentioned in the above prescription.
Correction:
Injection Regular Insulin 0 .4-0.8 units/kg/day.
Re-writing:
Date:
Patient’s name – XYZ Physician’s details
Age- Name -
Gender- Reg. no.-
Address- Address-
Phone no.-
Rx.
Injection regular Insulin vial
Sig. 0.4-0.8 units/kg/day subcutaneously in divided doses.
Advice- Blood sugar monitoring
Dicyclomine- 50mg
Metronidazole- 800mg
Ranitidine - 150 mg thrice daily
Bethnechol- 50 mg orally.
General criticism:
1. Doctor’s and patient’s information are not given.
2. Symbol Rx is not given.
3. Dosage form of the drugs are not mentioned
Drug criticism:
1. Atropine sulphate cannot be used as it has many side effects.
2. Dicyclomine is the preferred drug in this case as it relaxes the smooth muscle.
3. Metronidazole and ranitidine are not used in such situations.
4. Bethnachol should not be used, as it is a cholinomimetic drug. It will increase the colicky
pain and aggravate the situation.
Dose criticism:
The given dose of dicyclomine is high.
Correction:
Injection Dicyclomine 10 mg/ml (i.m only)
Re-writing:
Date:
Patient’s name – XYZ Physician’s detail
Age- Name -
Gender- Reg. no.-
Address- Address-
Phone no.-
Rx.
Injection Dicyclomine 10 mg/ml
Sig. 2 ml intramuscular injection stat and 6 hourly if symptom persist
Physician’s signature with date